Emerald Health Sciences
Advancing the pharmaceutical industry through cutting edge cannabinoid science.
We draw on our leadership’s deep expertise in building life science companies to identify candidate companies with the greatest potential for contributing to the Emerald vision – to advance innovation in cannabinoid science to allay human suffering.
We support the growth of our portfolio companies as proactive partners. Our leaders serve as board members to help guide management teams and to create effective exit strategies.
We see enormous opportunity for innovation in the cannabinoid-derived pharmaceutical industry. Emerald supports and facilitates scientific collaboration and business development with its portfolio companies. We foster innovation in the discovery and development of breakthrough products in the pharmaceutical development of cannabinoid-derived drug products– an industry that is still in its infancy.
We believe that, over time, cannabinoid-derived drug products will disrupt and drive innovation in the pharmaceutical industry. Emerald has positioned its family of companies to further the understanding and development of drug products impacting the human endo-cannabinoid system.